Cargando…

Astragalus membranaceus Inhibits Inflammation via Phospho-P38 Mitogen-Activated Protein Kinase (MAPK) and Nuclear Factor (NF)-κB Pathways in Advanced Glycation End Product-Stimulated Macrophages

Advanced glycation end products (AGEs) and inflammation contribute to the development of diabetic complications. Astragalus membranaceus has properties of immunological regulation in many diseases. The aim of this study was to determine the function of A. membranaceus extract (AME) on the AGE-induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Qiaojing, Niu, Jianying, Wang, Zhaoxia, Xu, Wangjie, Qiao, Zhongdong, Gu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430240/
https://www.ncbi.nlm.nih.gov/pubmed/22942709
http://dx.doi.org/10.3390/ijms13078379
_version_ 1782241918966562816
author Qin, Qiaojing
Niu, Jianying
Wang, Zhaoxia
Xu, Wangjie
Qiao, Zhongdong
Gu, Yong
author_facet Qin, Qiaojing
Niu, Jianying
Wang, Zhaoxia
Xu, Wangjie
Qiao, Zhongdong
Gu, Yong
author_sort Qin, Qiaojing
collection PubMed
description Advanced glycation end products (AGEs) and inflammation contribute to the development of diabetic complications. Astragalus membranaceus has properties of immunological regulation in many diseases. The aim of this study was to determine the function of A. membranaceus extract (AME) on the AGE-induced inflammatory response in Ana-1 macrophages. The viability of cells treated with AME or AGEs was evaluated with the MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] method. The secretion and mRNA levels of IL-1β and TNF-α were measured by ELISA and RT-PCR, respectively. The activity of NF-κB was assayed by EMSA. The phosphorylation of p38 MAPK was assessed by western blotting. The results showed that AME was not toxic to macrophages. The treatment of macrophages with AME effectively inhibited AGE-induced IL-1β and TNF-α secretion and mRNA expression in macrophages. These effects may be mediated by p38 MAPK and the NF-κB pathway. The results suggest that AME can inhibit AGE-induced inflammatory cytokine production to down-regulate macrophage-mediated inflammation via p38 MAPK and NF-κB signaling pathways and indicate that AME could be an immunoregulatory agent against AGE-induced inflammation in diabetes.
format Online
Article
Text
id pubmed-3430240
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-34302402012-08-31 Astragalus membranaceus Inhibits Inflammation via Phospho-P38 Mitogen-Activated Protein Kinase (MAPK) and Nuclear Factor (NF)-κB Pathways in Advanced Glycation End Product-Stimulated Macrophages Qin, Qiaojing Niu, Jianying Wang, Zhaoxia Xu, Wangjie Qiao, Zhongdong Gu, Yong Int J Mol Sci Article Advanced glycation end products (AGEs) and inflammation contribute to the development of diabetic complications. Astragalus membranaceus has properties of immunological regulation in many diseases. The aim of this study was to determine the function of A. membranaceus extract (AME) on the AGE-induced inflammatory response in Ana-1 macrophages. The viability of cells treated with AME or AGEs was evaluated with the MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide] method. The secretion and mRNA levels of IL-1β and TNF-α were measured by ELISA and RT-PCR, respectively. The activity of NF-κB was assayed by EMSA. The phosphorylation of p38 MAPK was assessed by western blotting. The results showed that AME was not toxic to macrophages. The treatment of macrophages with AME effectively inhibited AGE-induced IL-1β and TNF-α secretion and mRNA expression in macrophages. These effects may be mediated by p38 MAPK and the NF-κB pathway. The results suggest that AME can inhibit AGE-induced inflammatory cytokine production to down-regulate macrophage-mediated inflammation via p38 MAPK and NF-κB signaling pathways and indicate that AME could be an immunoregulatory agent against AGE-induced inflammation in diabetes. Molecular Diversity Preservation International (MDPI) 2012-07-05 /pmc/articles/PMC3430240/ /pubmed/22942709 http://dx.doi.org/10.3390/ijms13078379 Text en © 2012 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Qin, Qiaojing
Niu, Jianying
Wang, Zhaoxia
Xu, Wangjie
Qiao, Zhongdong
Gu, Yong
Astragalus membranaceus Inhibits Inflammation via Phospho-P38 Mitogen-Activated Protein Kinase (MAPK) and Nuclear Factor (NF)-κB Pathways in Advanced Glycation End Product-Stimulated Macrophages
title Astragalus membranaceus Inhibits Inflammation via Phospho-P38 Mitogen-Activated Protein Kinase (MAPK) and Nuclear Factor (NF)-κB Pathways in Advanced Glycation End Product-Stimulated Macrophages
title_full Astragalus membranaceus Inhibits Inflammation via Phospho-P38 Mitogen-Activated Protein Kinase (MAPK) and Nuclear Factor (NF)-κB Pathways in Advanced Glycation End Product-Stimulated Macrophages
title_fullStr Astragalus membranaceus Inhibits Inflammation via Phospho-P38 Mitogen-Activated Protein Kinase (MAPK) and Nuclear Factor (NF)-κB Pathways in Advanced Glycation End Product-Stimulated Macrophages
title_full_unstemmed Astragalus membranaceus Inhibits Inflammation via Phospho-P38 Mitogen-Activated Protein Kinase (MAPK) and Nuclear Factor (NF)-κB Pathways in Advanced Glycation End Product-Stimulated Macrophages
title_short Astragalus membranaceus Inhibits Inflammation via Phospho-P38 Mitogen-Activated Protein Kinase (MAPK) and Nuclear Factor (NF)-κB Pathways in Advanced Glycation End Product-Stimulated Macrophages
title_sort astragalus membranaceus inhibits inflammation via phospho-p38 mitogen-activated protein kinase (mapk) and nuclear factor (nf)-κb pathways in advanced glycation end product-stimulated macrophages
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3430240/
https://www.ncbi.nlm.nih.gov/pubmed/22942709
http://dx.doi.org/10.3390/ijms13078379
work_keys_str_mv AT qinqiaojing astragalusmembranaceusinhibitsinflammationviaphosphop38mitogenactivatedproteinkinasemapkandnuclearfactornfkbpathwaysinadvancedglycationendproductstimulatedmacrophages
AT niujianying astragalusmembranaceusinhibitsinflammationviaphosphop38mitogenactivatedproteinkinasemapkandnuclearfactornfkbpathwaysinadvancedglycationendproductstimulatedmacrophages
AT wangzhaoxia astragalusmembranaceusinhibitsinflammationviaphosphop38mitogenactivatedproteinkinasemapkandnuclearfactornfkbpathwaysinadvancedglycationendproductstimulatedmacrophages
AT xuwangjie astragalusmembranaceusinhibitsinflammationviaphosphop38mitogenactivatedproteinkinasemapkandnuclearfactornfkbpathwaysinadvancedglycationendproductstimulatedmacrophages
AT qiaozhongdong astragalusmembranaceusinhibitsinflammationviaphosphop38mitogenactivatedproteinkinasemapkandnuclearfactornfkbpathwaysinadvancedglycationendproductstimulatedmacrophages
AT guyong astragalusmembranaceusinhibitsinflammationviaphosphop38mitogenactivatedproteinkinasemapkandnuclearfactornfkbpathwaysinadvancedglycationendproductstimulatedmacrophages